In Episode 32 of Hims House, hosts Jonathan Stern and Patrick Lester (aka Bayside) are joined by Antonio Linares — early Tesla and AMD investor, and one of the biggest Hims bulls on earth. Antonio lays out his long-term thesis: Hims isn’t just a telehealth brand, it’s a platform applying the Costco algorithm to healthcare, with world-class execution, a proprietary data loop, and the potential to birth an AI-driven digital twin of the human body.
The discussion covers the explosive potential of peptides, the role of network effects and personalized manufacturing, and why traditional pharma and Wall Street still underestimate Hims’ moat. Antonio also unpacks his concentrated investment strategy and the dynamics of retail vs. institutional conviction.
00:00 Introduction
01:00 Antonio's Investment Philosophy
02:15 The Costco Algorithm Applied to Healthcare
07:22 Comparing Hims to Other Tech Giants
10:51 Antonio's Approach to Portfolio Construction
18:50 Hims as a Platform & Tech Company
28:07 The Role of Data and AI in Healthcare
38:06 Peptides
42:35 Hims and Traditional Pharma
51:40 Andrew Dudum and Management
56:40 "Hims is a 100x. From Here."
01:08:48 Retail vs. Wall Street
Get full access to Hims House at
himshouse.substack.com/subscribe
